Since PTEN (and regulatory RNAs such as PTENP1 or miR-96-5p) are actively packed into these EVs and remain functionally intact, measuring their levels in patient fluids can provide a real-time picture of tumor suppressor activity and changes in the TME [78]. The gene discussed is PTEN; the disease is neoplasm.